PAPER Bloemers BL, van Bleek GM, Kimpen JL, Bont L
SEARCH RESULTS
331171 RESULTS
PAPER Fishman-Jacob T, Youdim MB, Mandel SA
Silencing/overexpressing selected genes as a model of sporadic Parkinson's disease.
Neurodegener Dis. 2010;7(1-3):108-11. PubMed: 20173338PAPER Urbach YK, Bode FJ, Nguyen HP, Riess O, von Hörsten S
Neurobehavioral tests in rat models of degenerative brain diseases.
Methods Mol Biol. 2010;597:333-56. PubMed: 20013245PAPER Wood NI, Carta V, Milde S, Skillings EA, McAllister CJ, Ang YL, Duguid A, Wijesuriya N, Afzal SM, Fernandes JX, Leong TW, Morton AJ, Morton J
Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease.
PLoS One. 2010;5(2):e9077. PubMed: 20174443PAPER Natale M, Bonino D, Consoli P, Alberio T, Ravid RG, Fasano M, Bucci EM
A meta-analysis of two-dimensional electrophoresis pattern of the Parkinson's disease-related protein DJ-1.
Bioinformatics. 2010 Apr 1;26(7):946-52. PubMed: 20172943PAPER Wild P, Dikic I
Mitochondria get a Parkin' ticket.
Nat Cell Biol. 2010 Feb;12(2):104-6. PubMed: 20118996PAPER Yoneshige A, Suzuki K, Matsuda J
A mutation in the saposin C domain of the sphingolipid activator protein (Prosaposin) gene causes neurodegenerative disease in mice.
J Neurosci Res. 2010 Aug 1;88(10):2118-34. PubMed: 20175216PAPER Indulekha CL, Sanalkumar R, Thekkuveettil A, James J
Seizure induces activation of multiple subtypes of neural progenitors and growth factors in hippocampus with neuronal maturation confined to dentate gyrus.
Biochem Biophys Res Commun. 2010 Mar 19;393(4):864-71. PubMed: 20171185PAPER Alkam T, Nitta A, Furukawa-Hibi Y, Niwa M, Mizoguchi H, Yamada K, Nabeshima T
Oral supplementation with Leu-Ile, a hydrophobic dipeptide, prevents the impairment of memory induced by amyloid beta in mice via restraining the hyperphosphorylation of extracellular signal-regulated kinase.
Behav Brain Res. 2010 Jul 11;210(2):184-90. PubMed: 20171988PAPER Gauthier S, Leuzy A
Diagnosis of prodromal Alzheimer's disease: do you really want to know?
Can J Neurol Sci. 2010 Jan;37(1):2. PubMed: 20169766PAPER Habek M, Hajnsek S, Zarković K, Chudy D, Mubrin Z
Frontal variant of Alzheimer's disease: clinico-CSF-pathological correlation.
Can J Neurol Sci. 2010 Jan;37(1):118-20. PubMed: 20169785PAPER Gravius A, Pietraszek M, Dekundy A, Danysz W
Metabotropic glutamate receptors as therapeutic targets for cognitive disorders.
Curr Top Med Chem. 2010;10(2):187-206. PubMed: 20170472PAPER Arawaka S, Machiya Y, Kato T
Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases.
Curr Pharm Biotechnol. 2010 Feb;11(2):158-66. PubMed: 20170473PAPER Mowszowski L, Batchelor J, Naismith SL
Early intervention for cognitive decline: can cognitive training be used as a selective prevention technique?
Int Psychogeriatr. 2010 Jun;22(4):537-48. PubMed: 20170585PAPER Okahara K, Ishida Y, Hayashi Y, Inoue T, Tsuruta K, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Yoshida K, Noda S, Tomita S, Fujimoto M, Hosomi J, Mitsuyama Y
Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):532-6. PubMed: 20170698Current Filters
No filters selected